Manipulation of the JAK-STAT pathway may represent a novel therapeutic strategy for mitochondrial diseases, by fine-tuning the balance of mitochondrial fission and fusion. This evidence concerns the gene SOAT1 and inborn mitochondrial metabolism disorder.